Pharmaconutrition in Practice: How Pharmacists Can Lead the Way in Patient Nutrition and Wellness
Lara Zakaria, PharmD, introduced the topic of pharmaconutrition, urging pharmacists to integrate food, lifestyle, and gut health into patient care…
Lumateperone Submits Application for Schizophrenia Indication to FDA for Supplemental New Drug
Lumatperone showed a 63% reduction in relapse risk for patients with schizophrenia, promising improved patient stability and care.
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
Gustavo Alva, MD, a board-certified psychiatrist, discusses the importance of mental health awareness among both pharmacists and patients.
With Proper Adherence to Cholesterol-Lowering Drugs, Thousands of Cardiovascular Events Could Be Avoided
By closing the gap on patients recommended lipid-lowering therapies who do not receive them, researchers say that thousands of cardiovascular…
FDA Grants Full Approval to mRNA-1273 COVID-19 Vaccine in Children At Increased Risk
mRNA-1273, marketed as Spikevax by Moderna, is now fully approved for individuals aged 6 months through 64 years with high-risk…
ATOPP 2025: Pharmacy Innovation at the Intersection of EOM and Patient Access
Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, FAPO, discusses how oncology pharmacists can lead value-based care efforts under the Enhanced…
Breaking Through Misconceptions: How Pharmacists Can Shift the Conversation for Vaccines
An expert discusses how pharmacists can overcome common vaccination barriers by addressing misconceptions about vaccine necessity, making strong provider recommendations,…
1042: Early Norepinephrine Use in Septic Shock is Associated with Reduced Mortality
Show notes at pharmacyjoe.com/episode1042. In this episode, I’ll discuss early vs delayed norepinephrine use in patients with septic shock. The…